Showing results (31-40 of 270,758) with videos related to
Sort By:
Pageof 27,076
Current Medical Research and Opinion|December 15, 2018
Impact of dose capping in insulin glargine/lixisenatide fixed-ratio combination trials in patients with type 2 diabetesWolfgang Schmider, Rene Belder, Michelle Lee, et al.Analytical Biochemistry|February 15, 2005
6,8-Difluoro-4-methylumbiliferyl phosphate: a fluorogenic substrate for protein tyrosine phosphatasesStefan Welte, Karl-Heinz Baringhaus, Wolfgang Schmider, et al.Journal of Cancer Research and Clinical Oncology|December 6, 2005
Cyclin-dependent kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancerAnnette Schmider-Ross, Olaf Pirsig, Elisabeth Gottschalk, et al.Clinical Pharmacology and Therapeutics|October 11, 2018
Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case ProcessingJuergen Schmider, Krishan Kumar, Chantal LaForest, et al.Clinical Pharmacology in Drug Development|February 15, 2022
Similar Pharmacokinetics and Pharmacodynamics of Biosimilar SAR342434 Insulin Lispro and Japan-Approved Humalog Insulin Lispro in Healthy Japanese SubjectsMasanari Shiramoto, Tatsuya Yoshihara, Wolfgang Schmider, et al.Scientific Reports|November 26, 2021
Pharmacokinetic and pharmacodynamic similarity between SAR341402 insulin aspart and Japan-approved NovoRapid in healthy Japanese subjectsMasanari Shiramoto, Tatsuya Yoshihara, Wolfgang Schmider, et al.Indian Journal of Endocrinology and Metabolism|October 3, 2022
Pharmacokinetic Similarity between Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 and Originator Insulin Aspart Mix 70/30 (NovoMix 30) in Indian Adults with Type 2 Diabetes: GEMELLI M SubstudyViswanathan Mohan, Wolfgang Schmider, Kiran P Singh, et al.British Journal of Clinical Pharmacology|February 12, 1998
Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p-hydroxylationJ Schmider, D J Greenblatt, L L von Moltke, et al.Biological Psychiatry|December 15, 1995
Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: IJ Schmider, C H Lammers, U Gotthardt, et al.Clinical Pharmacokinetics|January 1, 1995
Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacologyL L von Moltke, D J Greenblatt, J Schmider, et al.Pageof 27,076